Cases & Deals

LeaderMed Health Group Limited enters into joint venture and licensing agreement with OPKO Health to develop and commercialize innovative drugs in Asian countries

Client(s) Leadermed Health Group Limited

Jones Day represented LeaderMed Health Group Limited in the formation of a joint venture and exclusive license agreement with OPKO Health, Inc. ("OPKO") to develop, manufacture, and commercialize two of OPKO's clinical stage, long-acting drug products, Oxyntomodulin and Factor VIIa-CTP, in Greater China and eight other Asian territories.